Abstract
Objective
To describe infection epidemiology and measure antibiotic utilization among a large cohort of newborns with congenital diaphragmatic hernia (CDH).
Study design
Retrospective observational study including inborn newborns with CDH at a level IV referral center (free-standing children’s hospital with special delivery unit) and two associated level III birth centers who underwent active care and survived to NICU admission, born 1/2013-11/2022 with available disposition.
Results
Of 381 newborns with CDH who were admitted to the NICU, 370 (97.1%) received antibiotics. There were 137 (36.1%) newborns with a positive bacterial culture from any source; 78/381 (20.4%) had a positive culture from blood, urine, or spinal fluid.
Conclusion
Nearly all newborns with CDH at our center received antibiotics during their hospitalization, but the majority did not have a positive bacterial culture result, indicating opportunities exist for antibiotic stewardship among this population.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The datasets generated and analyzed during the current study are not publicly available due to institutional data use restrictions, but are available from the corresponding author on reasonable request. All relevant summary data supporting the conclusions of this article are presented within the manuscript and its supplementary materials. There are no restrictions on material availability beyond those described.
References
Keijzer R, Puri P. Congenital diaphragmatic hernia. Semin Pediatr Surg. 2010;19:180–5.
Keene S, Murthy K, Pallotto E, Brozanski B, Gien J, Zaniletti I, et al. Acquired infection and antimicrobial utilization during Initial NICU hospitalization in infants with congenital diaphragmatic hernia. Pediatr Infect Dis J. 2018;37:469–74.
Cox LM, Yamanishi S, Sohn J, Alekseyenko AV, Leung JM, Cho I, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell. 2014;158:705–21.
Flannery DD, Chiotos K, Gerber JS, Puopolo KM. Neonatal multidrug-resistant gram-negative infection: epidemiology, mechanisms of resistance, and management. Pediatr Res. 2022;91:380–91. Nature Publishing Group
Flannery DD, Horbar JD. Metrics of neonatal antibiotic use. Semin Perinatol. 2020;44:151329.
Flannery DD, Puopolo KM. Neonatal antibiotic use: what are we doing and where shall we go? Neoreviews. 2018;19:e516–25.
Puopolo KM, Benitz WE, Zaoutis TE. Management of neonates born at ≥35 0/7 weeks’ gestation with suspected or proven early-onset bacterial sepsis. Pediatrics. 2018;142:20182894.
Puopolo KM, Benitz WE, Zaoutis TE. Management of neonates born at ≤34 6/7 weeks’ gestation with suspected or proven early-onset bacterial sepsis. Pediatrics. 2018;142:e20182896.
Puopolo KM, Mukhopadhyay S, Hansen NI, Michael Cotten C, Stoll BJ, Sanchez PJ, et al. Identification of Extremely Premature Infants at Low Risk for Early-Onset Sepsis. Pediatrics. 2017;140:e20170925.
Reynolds TA, Goldshore MA, Flohr S, Land S, Mathew L, Gebb JS, et al. A clinical outcomes data archive for a comprehensive fetal diagnosis and treatment center. Fetal Diagn Ther. 2025;52:139–47.
DeKoninck P, Gratacos E, Van Mieghem T, Richter J, Lewi P, Ancel AM, et al. Results of fetal endoscopic tracheal occlusion for congenital diaphragmatic hernia and the set up of the randomized controlled TOTAL trial. Early Hum Dev. 2011;87:619–24.
Mukhopadhyay S, Puopolo KM. Neonatal early-onset sepsis: epidemiology and risk assessment. Neoreviews. 2015;16:e221–30.
Flannery DD, Puopolo KM. Neonatal early-onset sepsis. Neoreviews. 2022;23:756–70.
Stoll BJ, Puopolo KM, Hansen NI, Sánchez PJ, Bell EF, Carlo WA, et al. Early-onset neonatal sepsis 2015 to 2017, the rise of escherichia coli, and the need for novel prevention strategies. JAMA Pediatr. 2020;174:1–12.
Flannery DD, Akinboyo IC, Mukhopadhyay S, Tribble AC, Song L, Chen F, et al. Antibiotic Susceptibility of Escherichia coli among Infants Admitted to Neonatal Intensive Care Units across the US from 2009 to 2017. JAMA Pediatrics. 2021;175:168–75. American Medical Association
Flannery DD, Puopolo KM, Hansen NI, Gerber JS, Sánchez PJ, Stoll BJ. Antimicrobial susceptibility profiles among neonatal early-onset sepsis pathogens. Pediatr Infect Dis J. 2022;41:263–71.
Flannery DD, Mukhopadhyay S, Morales KH, Dhudasia MB, Passarella M, Gerber JS, et al. Delivery characteristics and the risk of early-onset neonatal sepsis. Pediatrics. 2022;149:e2021052900.
Claassen CC, Keenan WJ. Challenging the “Culture” of the tracheal aspirate. Neoreviews. 2019;20:e145–51.
Coggins SA, Glaser K. Updates in late-onset sepsis: risk assessment, therapy, and outcomes. Neoreviews. 2022;23:738–55.
Arattu Thodika FMS, Dassios T, Deep A, Greenough A. Acute kidney injury in infants with congenital diaphragmatic hernia. J Perinatol. 2022;42:925–9.
Jean-Baptiste N, Benjamin DK, Cohen-Wolkowiez M, Fowler VG, Laughon M, Clark RH, et al. Coagulase-negative staphylococcal infections in the neonatal intensive care unit. Infect Control Hosp Epidemiol. 2011;32:679–86.
Ericson JE, Thaden J, Cross HR, Clark RH, Fowler VG, Benjamin DK, et al. No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infants. Pediatr Infect Dis J. 2015;34:371–5.
Cantey JB, Anderson KR, Kalagiri RR, Mallett LH. Morbidity and mortality of coagulase-negative staphylococcal sepsis in very-low-birth-weight infants. World J Pediatr. 2018;14:269–73.
Magers J, Prusakov P, Speaks S, Conroy S, Sánchez PJ. Safety and efficacy of nafcillin for empiric therapy of late-onset sepsis in the NICU. Pediatrics. 2022;149:e2021052360.
Lawrence SL, Roth V, Slinger R, Toye B, Gaboury I, Lemyre B Cloxacillin versus vancomycin for presumed late-onset sepsis in the Neonatal Intensive Care Unit and the impact upon outcome of coagulase negative staphylococcal bacteremia: a retrospective cohort study. BMC Pediatr. 2005;5:49.
Hamdy RF, Bhattarai S, Basu SK, Hahn A, Stone B, Sadler ED, et al. Reducing vancomycin use in a level IV NICU. Pediatrics. 2020;146:e20192963.
Chiu CH, Michelow IC, Cronin J, Ringer SA, Ferris TG, Puopolo KM. Effectiveness of a guideline to reduce vancomycin use in the neonatal intensive care unit. Pediatr Infect Dis J. 2011;30:273–8.
Petel DS, Isabel S, Lee K-S, Ting JY, Kaufman DA, Sanchez PJ, et al. Empiric antibiotic prescribing practices for gram-positive coverage of late-onset sepsis in neonatal intensive care units in North America. Infect Control Hosp Epidemiol. 2024;46:1–3.
Berriós-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al. Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152:784–91.
Gottschalk A, Coggins S, Dhudasia MB, Flannery DD, Healy T, Puopolo KM, et al. Utility of anaerobic blood cultures in neonatal sepsis evaluation. J Pediatr Infect Dis Soc. 2024;13:406–12.
Funding
This study was not funded. DDF reports receiving K08 funding from the Agency for Healthcare Research and Quality, unrelated to the current study.
Author information
Authors and Affiliations
Contributions
SJF and DDF conceptualized and designed the study. SJF and DDF conducted the data analysis with support from LM and TAM. HLH and NER provided clinical expertise in the surgical and neonatal care of infants with CDH. SKS, JSG, and AKM contributed to interpreting infectious disease and stewardship-related findings. SJF and DDF drafted the initial manuscript, and all authors provided critical revisions. All authors reviewed and approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval
This study was approved and deemed an exempt review type by the Institutional Review Board at the Children’s Hospital of Philadelphia (IRB 21-018553). Informed consent was not obtained due to the study being deemed minimal risk and the Institutional Review Board granting a waiver of HIPAA authorization for accessing identifiable information from the medical record. All methods of this study were performed according to the Declaration of Helsinki.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Flohr, S.J., Mathew, L., Hedrick, H.L. et al. Antibiotic exposure and infection epidemiology among newborns with congenital diaphragmatic hernia. J Perinatol 45, 1255–1261 (2025). https://doi.org/10.1038/s41372-025-02389-9
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41372-025-02389-9


